PGPKY yields 43.67% · JNJ yields 2.13%● Live data
📍 JNJ pulled ahead of the other in Year 10
Combined, PGPKY + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of PGPKY + JNJ for your $10,000?
PGE Polska Grupa Energetyczna S.A. engages in the production, transmission, and distribution of electricity in Poland. The company operates through seven segments: Conventional Generation, District Heating, Renewables, Supply, Distribution, Circular Economy, and Other Operations. It generates electricity from lignite, hard coal, natural gas, and biomass, as well as renewable energy sources, such as wind, photovoltaic, and hydro. The company operates 5 conventional power plants; 16 CHP plants; 2 lignite mines; 17 wind farms; 5 photovoltaic power plants; 29 run-of-river hydro power plants; and 4 pumped-storage power plants, including 2 with natural flow. It produces, transmits, and distributes heat; sells and purchases electricity and gas on wholesale market; trades in emission certificates; and purchases and sells fuels, as well as sells electricity and provides services to end users. The company supplies power to approximately 5 million households, businesses, and institutions. The company was founded in 1990 and is based in Warsaw, Poland.
Full PGPKY Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.